Apogee Therapeutics, Inc. Payments of Stock Issuance Costs
Apogee Therapeutics, Inc. (APGE) reported Payments of Stock Issuance Costs of $25.06 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-10
- Apogee Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $25.06M.
- Apogee Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2024-03-31 was $33.05M.
- Apogee Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2023-09-30 was $29.67M.
- Apogee Therapeutics, Inc. payments of stock issuance costs for fiscal 2023 was $29.67M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|
| 2026-03-31 | $25.06M 10-Q · filed 2026-08-10 | ||
| 2024-03-31 | $33.05M 10-Q · filed 2025-11-10 | ||
| 2023-12-31 | $29.67M 10-K · filed 2024-03-05 | ||
| 2023-09-30 | $29.67M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $1.69M 10-Q · filed 2024-08-12 |